OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Genetic Determinants for Prediction of Outcome of Patients with Papillary Thyroid Carcinoma
Antónia Póvoa, Elisabete Teixeira, María Rosa Bella, et al.
Cancers (2021) Vol. 13, Iss. 9, pp. 2048-2048
Open Access | Times Cited: 27
Antónia Póvoa, Elisabete Teixeira, María Rosa Bella, et al.
Cancers (2021) Vol. 13, Iss. 9, pp. 2048-2048
Open Access | Times Cited: 27
Showing 1-25 of 27 citing articles:
Genomic alterations in thyroid cancer: biological and clinical insights
Iñigo Landa, Maria E. Cabanillas
Nature Reviews Endocrinology (2023) Vol. 20, Iss. 2, pp. 93-110
Closed Access | Times Cited: 43
Iñigo Landa, Maria E. Cabanillas
Nature Reviews Endocrinology (2023) Vol. 20, Iss. 2, pp. 93-110
Closed Access | Times Cited: 43
Preoperative evaluation of thyroid nodules – Diagnosis and management strategies
Dana Antonia Țăpoi, Lambrescu Ioana Maria, Gheorghisan-Galateanu Ancuta-Augustina
Pathology - Research and Practice (2023) Vol. 246, pp. 154516-154516
Open Access | Times Cited: 12
Dana Antonia Țăpoi, Lambrescu Ioana Maria, Gheorghisan-Galateanu Ancuta-Augustina
Pathology - Research and Practice (2023) Vol. 246, pp. 154516-154516
Open Access | Times Cited: 12
Comparative Cyto-Histological Genetic Profile in a Series of Differentiated Thyroid Carcinomas
Maria de Lurdes Matos, Mafalda Pinto, Marta Alves, et al.
Diagnostics (2024) Vol. 14, Iss. 3, pp. 278-278
Open Access | Times Cited: 4
Maria de Lurdes Matos, Mafalda Pinto, Marta Alves, et al.
Diagnostics (2024) Vol. 14, Iss. 3, pp. 278-278
Open Access | Times Cited: 4
IRS1 promotes thyroid cancer metastasis through EMT and PI3K/AKT pathways
Fang Yu, Dongdong Huang, Yeye Kuang, et al.
Clinical Endocrinology (2024) Vol. 100, Iss. 3, pp. 284-293
Closed Access | Times Cited: 3
Fang Yu, Dongdong Huang, Yeye Kuang, et al.
Clinical Endocrinology (2024) Vol. 100, Iss. 3, pp. 284-293
Closed Access | Times Cited: 3
TERT Promoter Mutations Are an Independent Predictor of Distant Metastasis in Middle Eastern Papillary Thyroid Microcarcinoma
Sandeep Kumar Parvathareddy, Abdul K. Siraj, Kaleem Iqbal, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 15
Sandeep Kumar Parvathareddy, Abdul K. Siraj, Kaleem Iqbal, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 15
Applications of spatially resolved omics in the field of endocrine tumors
Yinuo Hou, Yan Gao, Shudi Guo, et al.
Frontiers in Endocrinology (2023) Vol. 13
Open Access | Times Cited: 9
Yinuo Hou, Yan Gao, Shudi Guo, et al.
Frontiers in Endocrinology (2023) Vol. 13
Open Access | Times Cited: 9
Profile of BRAFV600E, BRAFK601E, NRAS, HRAS, and KRAS Mutational Status, and Clinicopathological Characteristics of Papillary Thyroid Carcinoma in Indonesian National Referral Hospital
Agnes Stephanie Harahap, Imam Subekti, Sonar Soni Panigoro, et al.
The Application of Clinical Genetics (2023) Vol. Volume 16, pp. 99-110
Open Access | Times Cited: 7
Agnes Stephanie Harahap, Imam Subekti, Sonar Soni Panigoro, et al.
The Application of Clinical Genetics (2023) Vol. Volume 16, pp. 99-110
Open Access | Times Cited: 7
A Critical Assessment of Diagnostic Criteria for the Tall Cell Subtype of Papillary Thyroid Carcinoma—How Much? How Tall? And When Is It Relevant?
John Turchini, Talia L. Fuchs, Angela Chou, et al.
Endocrine Pathology (2023) Vol. 34, Iss. 4, pp. 461-470
Open Access | Times Cited: 7
John Turchini, Talia L. Fuchs, Angela Chou, et al.
Endocrine Pathology (2023) Vol. 34, Iss. 4, pp. 461-470
Open Access | Times Cited: 7
The prognostic power of gene mutations in thyroid cancer
Sara Ahmadi, Iñigo Landa
Endocrine Connections (2023) Vol. 13, Iss. 2
Open Access | Times Cited: 7
Sara Ahmadi, Iñigo Landa
Endocrine Connections (2023) Vol. 13, Iss. 2
Open Access | Times Cited: 7
Decoding RAS mutations in thyroid cancer: A meta-analysis unveils specific links to distant metastasis and increased mortality
Isabel Riccio, Alexandra LaForteza, Madeleine B. Landau, et al.
American Journal of Otolaryngology (2024) Vol. 46, Iss. 1, pp. 104570-104570
Open Access | Times Cited: 2
Isabel Riccio, Alexandra LaForteza, Madeleine B. Landau, et al.
American Journal of Otolaryngology (2024) Vol. 46, Iss. 1, pp. 104570-104570
Open Access | Times Cited: 2
Predictive Biomarkers in Thyroid Cancer
Elisabetta Macerola, Anello Marcello Poma, Paola Vignali, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 9
Elisabetta Macerola, Anello Marcello Poma, Paola Vignali, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 9
The Role of 5-Hydroxymethylcytosine as a Potential Epigenetic Biomarker in a Large Series of Thyroid Neoplasms
Şule Canberk, João Gonçalves, Elisabete Rios, et al.
Endocrine Pathology (2024) Vol. 35, Iss. 1, pp. 25-39
Open Access | Times Cited: 1
Şule Canberk, João Gonçalves, Elisabete Rios, et al.
Endocrine Pathology (2024) Vol. 35, Iss. 1, pp. 25-39
Open Access | Times Cited: 1
Multidisciplinary Canadian consensus on the multimodal management of high-risk and radioactive iodine-refractory thyroid carcinoma
Shereen Ezzat, Jesse D. Pasternak, Murali Rajaraman, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Shereen Ezzat, Jesse D. Pasternak, Murali Rajaraman, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Can We Predict Differentiated Thyroid Cancer Behavior? Role of Genetic and Molecular Markers
Rita Ničiporuka, Jurijs Nazarovs, Artūrs Ozoliņš, et al.
Medicina (2021) Vol. 57, Iss. 10, pp. 1131-1131
Open Access | Times Cited: 10
Rita Ničiporuka, Jurijs Nazarovs, Artūrs Ozoliņš, et al.
Medicina (2021) Vol. 57, Iss. 10, pp. 1131-1131
Open Access | Times Cited: 10
InTERTwined: How TERT promoter mutations impact BRAFV600E-driven thyroid cancers
Iñigo Landa
Current Opinion in Endocrine and Metabolic Research (2023) Vol. 30, pp. 100460-100460
Open Access | Times Cited: 3
Iñigo Landa
Current Opinion in Endocrine and Metabolic Research (2023) Vol. 30, pp. 100460-100460
Open Access | Times Cited: 3
Investigating USP42 Mutation as Underlying Cause of Familial Non-Medullary Thyroid Carcinoma
Elisabete Teixeira, Cláudia Fernandes, Raluca Maria Bungărdean, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1522-1522
Open Access
Elisabete Teixeira, Cláudia Fernandes, Raluca Maria Bungărdean, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1522-1522
Open Access
Relationship between Somatic Mutations and Clinic Pathological of Follicular Variant Papillary Thyroid Carcinoma: A MetaAnalysis
Qing‐Hua Fan
Journal on Surgery (2024) Vol. 4, Iss. 1
Open Access
Qing‐Hua Fan
Journal on Surgery (2024) Vol. 4, Iss. 1
Open Access
Follicular cell-derived thyroid carcinomas harboring novel genetic BRAFNON-V600E mutations: real-world data obtained using a multigene panel
Juliana Lima von Ammon, Gabriel Jeferson Rodríguez Machado, Rafael Reis Campos da Matta, et al.
Archives of Endocrinology and Metabolism (2024) Vol. 68
Open Access
Juliana Lima von Ammon, Gabriel Jeferson Rodríguez Machado, Rafael Reis Campos da Matta, et al.
Archives of Endocrinology and Metabolism (2024) Vol. 68
Open Access
Expression of CLDN1 and EGFR in PTC
J. T. Wu, Yaoming Wang, Lei Yan, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access
J. T. Wu, Yaoming Wang, Lei Yan, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access
Efficacy of Radioiodine in Non-Distant Metastatic Papillary Thyroid Cancer with TERT-p Mutation at Initial Diagnosis
Xianzhao Deng, Mengyue Liu, Chen‐Tian Shen, et al.
Research Square (Research Square) (2024)
Open Access
Xianzhao Deng, Mengyue Liu, Chen‐Tian Shen, et al.
Research Square (Research Square) (2024)
Open Access
Advances in Thyroid Carcinoma
Iñigo Landa
Cancers (2022) Vol. 14, Iss. 12, pp. 2908-2908
Open Access | Times Cited: 2
Iñigo Landa
Cancers (2022) Vol. 14, Iss. 12, pp. 2908-2908
Open Access | Times Cited: 2
Extremely aggressive course in a poorly differentiated thyroid carcinoma presenting a double mutation of the TERT promoter
Denise Engelbrecht Zantut‐Wittmann, A.C. Laus, Daniel Antunes Moreno, et al.
The American Journal of the Medical Sciences (2023) Vol. 365, Iss. 6, pp. 532-537
Closed Access
Denise Engelbrecht Zantut‐Wittmann, A.C. Laus, Daniel Antunes Moreno, et al.
The American Journal of the Medical Sciences (2023) Vol. 365, Iss. 6, pp. 532-537
Closed Access
Subcentimetric Papillary Thyroid Carcinoma: Does the Diagnosis Kind Impact Prognosis?
Diogo Ramalho, Elisabete Teixeira, María Rosa Bella, et al.
Cureus (2023)
Open Access
Diogo Ramalho, Elisabete Teixeira, María Rosa Bella, et al.
Cureus (2023)
Open Access
Subcentimetric papillary thyroid carcinoma with extensive lymph node and brain metastasis: case report and review of literature
Andreia Amado, Elisabete Teixeira, Şule Canberk, et al.
Endocrinology Diabetes and Metabolism Case Reports (2023) Vol. 2023, Iss. 4
Open Access
Andreia Amado, Elisabete Teixeira, Şule Canberk, et al.
Endocrinology Diabetes and Metabolism Case Reports (2023) Vol. 2023, Iss. 4
Open Access
Atypical Papillary Thyroid Carcinoma with Squamous Metaplasia and RET/NRAS/TERT/PIK3CA Mutations: A Case Report
Zhenyu Li, Haiping Huang, Dongfang Guo, et al.
Research Square (Research Square) (2022)
Open Access
Zhenyu Li, Haiping Huang, Dongfang Guo, et al.
Research Square (Research Square) (2022)
Open Access
